HomeYMAB • NASDAQ
Y-mAbs Therapeutics Inc
Follow
$14.71
After Hours: $14.71
Closed: Apr 26, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements Key events shows relevant news articles on days with large price movements
ORIC Pharmaceuticals Inc
$8.07
ORIC5.22%
Syndax Pharmaceuticals Inc
$21.06
SNDX2.38%
Rocket Pharmaceuticals Inc
$21.98
RCKT0.54%
Olema Pharmaceuticals Inc
$9.95
OLMA1.22%
Legend Biotech Corp
$45.30
LEGN1.98%
Cullinan Therapeutics Inc
$25.30
CGEM31.43%
Amicus Therapeutics, Inc.
$10.28
FOLD1.08%
ROIV
$11.03
ROIV1.38%
Inhibrx Inc
$34.06
INBX0.088%
Phathom Pharmaceuticals Inc
$9.18
PHAT0.88%
Financials
Income Statement
Revenue Net income Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24. Revenue The total amount of income generated by the sale of goods or services related to the company's primary operations Operating expense Represents the total incurred expenses through normal operations Net income Company’s earnings for a period net of operating costs, taxes, and interest Net profit margin Measures how much net income or profit is generated as a percentage of revenue. Earnings per share Represents the company's profit divided by the outstanding shares of its common stock. EBITDA Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances Effective tax rate The percent of their income that a corporation pays in taxes(USD) Dec 2023info Y/Y change 23.36M -25.71% 24.52M -18.16% -988.00K -185.39% -4.23 -214.95% -0.02 -166.67% -3.04M -892.81% -24.59% —
Balance Sheet
Total assets Total liabilities Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24. Cash and short-term investments Investments that are relatively liquid and have maturities between 3 months and one year Total assets The total amount of assets owned by a company Total liabilities Sum of the combined debts a company owes Total equity The value of subtracting the total liabilities from the total assets of a company Shares outstanding Total number of common shares outstanding as of the latest date disclosed in a financial filing Price to book A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock Return on assets A financial ratio that shows a company’s profitability compared to its assets Return on capital Company’s return above the average cost it pays for its debt and equity capital(USD) Dec 2023info Y/Y change 78.64M -25.65% 127.87M -9.61% 26.88M -16.60% 100.98M — 43.78M — 6.42 — -6.23% — -7.83% —
Cash Flow
Net change in cash Fiscal Q4 2023 ended 12/31/23. Reported on 2/29/24. Net income Company’s earnings for a period net of operating costs, taxes, and interest Cash from operations Net cash used or generated for core business activities Cash from investing Net cash used or generated in investing activities such as purchasing assets Cash from financing Net cash used or generated in financing activities such as dividend payments and loans Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period Free cash flow Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments(USD) Dec 2023info Y/Y change -988.00K -185.39% -8.04M 7.22% — — 100.00K — -7.93M 9.47% -11.05M -86.35%
Stock Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned Listed on NASDAQ
Previous close The last closing price
$14.84
Day range The range between the high and low prices over the past day
$14.36 - $15.13
Year range The range between the high and low prices over the past 52 weeks
$4.60 - $20.90
Market cap A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
643.96M USD
Avg Volume The average number of shares traded each day over the past 30 days
357.46K
P/E ratio The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange Listed exchange for this security
NASDAQ
About
Founded 2015 Website Employees 100
Discover more
You may be interested in
info This list is generated from recent searches, followed securities, and other activity. Learn more All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
People also search for
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
add_circle_outline
HelpSend feedbackPrivacyTermsDisclaimer
